company background image
VIMTALABS logo

Vimta Labs NSEI:VIMTALABS Stock Report

Last Price

₹940.00

Market Cap

₹20.9b

7D

-0.9%

1Y

88.8%

Updated

10 Jun, 2025

Data

Company Financials

Vimta Labs Limited

NSEI:VIMTALABS Stock Report

Market Cap: ₹20.9b

Vimta Labs (VIMTALABS) Stock Overview

Provides contract research and testing services in India and internationally. More details

VIMTALABS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends2/6

Rewards

Price-To-Earnings ratio (31.4x) is below the Life Sciences industry average (45.9x)

Earnings grew by 36.8% over the past year

Risk Analysis

Highly volatile share price over the past 3 months compared to the Indian market


VIMTALABS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Vimta Labs Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vimta Labs
Historical stock prices
Current Share Price₹940.00
52 Week High₹1,178.00
52 Week Low₹472.05
Beta-0.13
1 Month Change-0.89%
3 Month Change-10.01%
1 Year Change88.85%
3 Year Change196.02%
5 Year Change1,029.13%
Change since IPO3.47%

Recent News & Updates

Vimta Labs Limited's (NSE:VIMTALABS) CEO Looks Like They Deserve Their Pay Packet

May 31
Vimta Labs Limited's (NSE:VIMTALABS) CEO Looks Like They Deserve Their Pay Packet

Here's Why Vimta Labs (NSE:VIMTALABS) Has Caught The Eye Of Investors

May 16
Here's Why Vimta Labs (NSE:VIMTALABS) Has Caught The Eye Of Investors

Recent updates

Vimta Labs Limited's (NSE:VIMTALABS) CEO Looks Like They Deserve Their Pay Packet

May 31
Vimta Labs Limited's (NSE:VIMTALABS) CEO Looks Like They Deserve Their Pay Packet

Here's Why Vimta Labs (NSE:VIMTALABS) Has Caught The Eye Of Investors

May 16
Here's Why Vimta Labs (NSE:VIMTALABS) Has Caught The Eye Of Investors

There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 29% Price Jump

Feb 15
There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 29% Price Jump

Here's Why Vimta Labs (NSE:VIMTALABS) Has Caught The Eye Of Investors

Feb 07
Here's Why Vimta Labs (NSE:VIMTALABS) Has Caught The Eye Of Investors

Vimta Labs Limited's (NSE:VIMTALABS) 30% Share Price Surge Not Quite Adding Up

Dec 24
Vimta Labs Limited's (NSE:VIMTALABS) 30% Share Price Surge Not Quite Adding Up

Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%

Nov 09
Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%

There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump

Sep 06
There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump

It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package

Jul 12
It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package

Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly

Jun 12
Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly

Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost

Apr 26
Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost

It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)

Jan 06
It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)

If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity

Jul 14
If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity

Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00

Jun 03
Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00

Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00

May 06
Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00

A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)

Dec 07
A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)

Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today

Nov 06
Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today

Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

Jun 02
Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?

Dec 06
Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?

Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Oct 27
Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now

Jun 29
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now

Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Jun 19
Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Shareholder Returns

VIMTALABSIN Life SciencesIN Market
7D-0.9%2.0%2.8%
1Y88.8%37.1%3.5%

Return vs Industry: VIMTALABS exceeded the Indian Life Sciences industry which returned 35.5% over the past year.

Return vs Market: VIMTALABS exceeded the Indian Market which returned 3.8% over the past year.

Price Volatility

Is VIMTALABS's price volatile compared to industry and market?
VIMTALABS volatility
VIMTALABS Average Weekly Movement9.8%
Life Sciences Industry Average Movement7.1%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.4%

Stable Share Price: VIMTALABS's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: VIMTALABS's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19841,315Harita Vasireddivimta.com

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages.

Vimta Labs Limited Fundamentals Summary

How do Vimta Labs's earnings and revenue compare to its market cap?
VIMTALABS fundamental statistics
Market cap₹20.93b
Earnings (TTM)₹667.55m
Revenue (TTM)₹3.45b
31.4x
P/E Ratio
6.1x
P/S Ratio

Is VIMTALABS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIMTALABS income statement (TTM)
Revenue₹3.45b
Cost of Revenue₹855.18m
Gross Profit₹2.60b
Other Expenses₹1.93b
Earnings₹667.55m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 14, 2025

Earnings per share (EPS)30.00
Gross Margin75.24%
Net Profit Margin19.33%
Debt/Equity Ratio2.2%

How did VIMTALABS perform over the long term?

See historical performance and comparison

Dividends

0.2%
Current Dividend Yield
7%
Payout Ratio

Does VIMTALABS pay a reliable dividends?

See VIMTALABS dividend history and benchmarks
When do you need to buy VIMTALABS by to receive an upcoming dividend?
Vimta Labs dividend dates
Ex Dividend DateMay 30 2025
Dividend Pay DateJun 16 2025
Days until Ex dividend12 days
Days until Dividend pay date5 days

Does VIMTALABS pay a reliable dividends?

See VIMTALABS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/10 04:57
End of Day Share Price 2025/06/10 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vimta Labs Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Vijay MadunalaFirstCall Research